Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
It’s alright in here isn’t it. See the last people in here left a decade ago. They left some cheese in the fridge but I found some tea bags in the cupboard.
Let’s hope this new name brings about a change in fortunes, it’s been a very poor last 18 months. But I have bought back in, 200k shares at 0.8p. It’s a bit of a gamble but good news with the Stalicla deal would see this rise past 2p easily. Still have no idea what’s going on with it but there has to be news soon.
Give us an update on the dispute notice issued to Stalicla.
This is promising. An investment company isn’t going to buy 20m shares if they are no wiser than us about the prospects in the company. Looks like they have invested £150k in EVG shares. I’m optimistic something is going to happen here soon.
Yes, if the Stalicla deal is ok then this is a great buy in price. When I originally bought in after the Stalicla deal was announced, 200,000 shares cost around £9k -£10k. You can now get 200,000 shares for £1600. Maybe I’ll lose most of this but if EVG announces they have received the $500k plus expect the other $5m before the end of the year this increases 300% from here. If Stalicla make an offer for EVG you’d like to think they’ll have to pay £20m+ which is around 5p a share and a 600% increase. Of course if EVG announce the Stalicla deal is over then this plummets yet further.
It’s now ten weeks since the dispute notice was issued. What on earth is going on here? You would think that this would be resolved in a phone call, have we fulfilled our commitments for the $500k milestone payment or not? If not what have we not done?
The good news is that Stalicla have not pulled the plug.
I’m starting to think that Stalicla are reluctant to pay any money as they want to buy out EVG, it would save them a fortune compared to the $160m milestone payments plus royalties. Could that be why EVG acquired a new company and raised cash in order to show Stalicla that they won’t be pushed about and EVG are in no hurry to sell cheaply? Is it why we’ve finally seen some of the board finally buy some shares? It feels like Stalicla paid the original $500k to test out SFX-01 and then make a decision to scrap the deal or buy out EVG.
The above could be totally wrong but it is possible. It’s risky buying in here but I’m going to buy back in, only a few hundred thousand shares. I’m not encouraging anyone else to do the same, but just thought I’d share my views.
It’s a fair write up xxxinvestorxxx. It is a fair balanced view you’ve given and I can understand you wanting to be positive and optimistic.
I do agree with LWHL that everything does rest on the Stalicla deal, if that was to fall through then this is worthless and the fact there is some problem is alarming. On a positive note it’s almost 10 weeks since the dispute was issued and Stalicla haven’t pulled the plug but god knows what is going on. I am of the impression that Stalicla have a deal in place costing $160m plus royalties but have realised EVG is worth peanuts and why not try and pick up EVG for next to nothing if the SFX-01 is effective and save an absolute fortune. Maybe that’s why they are not paying the $500k and delaying moving this into phase 2?
I was feeling really confident that this would pass the 5p mark before the dividend qualifying date. The results were excellent and the outlook even better. The share price was riding the crest of a wave, kept up momentum to 499p. But it fell a bit before the ex dividend date and again after it. Seems to be struggling to climb right now.
Where do you see this heading short/medium term? I’m apprehensive to be honest. It seems to be kicking off in the Middle East which will no doubt hurt the markets. The FTSE is very high right now, I can’t see it rising much further. There are no dividends for a while now, I’m thinking maybe to exit for the time being and jump back in when things seem a bit calmer. What are others doing?
It has all gone very quiet on here. Has everyone given up on it? This share had so much support, investors who 100% believed in the company.
I am really puzzled why there is still no update two months on. It obviously isn’t an oversight like many of us hoped. But it was clear there were problems last summer when EVG changed its guidance of $5.5m to be received by end of 2023 to ‘up to $5.5m expected in 2024. That raised alarm bells for me and I fortunately sold out at 2.55p.
What is clear is that the board know a lot more than they have told the mug shareholders. For example issuing shares last month to dilute the shares by 50%, why do that if they are expecting money imminently, especially after the new finance guy talked about wanting to create value for shareholders when he was appointed. But clearly even the board are puzzled as they issued a dispute notice believing they fulfilled their commitments. It seems like Stalicla are an awkward partner, it doesn’t bode well for future payments if they can’t even honour the second one.
It’s just been a disastrous 18 months since the Stalicla deal was announced. I’d like to hear from posters like xxxInvestorxxx, K3VMC, Trickymatters, Mozax for their take on things. I know we’ve not always agreed but they were all very civil and reasonable.
So true. I’ve never seen a AIM company that makes year in year out healthy profits, shows growth and long term share price increases. Everyone I’ve touched has ended up going out of business. All they seem to be is a way for the founders of each company to earn a good salary for a few years before it goes into administration. AIM shares should be avoided at all costs.
8 weeks today since Evgen issued their dispute over milestone payment not received and still no updates. I mean what the af is going on here? Is it too much to expect the shareholders to have an update on this, after all the $5.5m was originally said to be received by end of 2023.
I suppose the one glimmer of light is that at least Stalicla haven’t pulled the plug on the deal.
All depends on the Stalicla deal. If it goes into phase 2 and EVG get the $5.5m milestone payments they have said they will get then things will look up. But god knows what is going on with that.
0.72p to sell now. The likes of Radar, Kingalf and I got a lot of criticism and called trolls for our negativity of this share. I hope some people will at least recognise we were just giving our realistic thoughts on the share. We’ve had a share dilution at 1p which we predicted, I seem to remember being told I was talking nonsense for that.
Yes it really is embarrassing, shows just how little confidence there is about Evgen. It really has been a disaster these last 18 months. Why are they not updating us about the Stalicla deal and payment dispute? It’s 8 weeks now, it’s ridiculous how they treat shareholders, they see shareholders as something brown that they’ve trodden in. Shareholders are an inconvenience to them that is for sure.
Was just checking the Stalicla website at the Pipeline and the arrow on STP2 has moved from being half way in phase one box to now showing as phase 1 complete. There is no change however to the text about STP2.
Not lost much this time. I bought in for 1p after the dispute notice was issued and made a 10% loss. I was really confident that this would be quickly resolved, the $500k milestone payment would be received (as EVG have said that they have fulfilled their obligations) and we would get confirmation that this would go into phase 2 this year (as advised on Stalicla website at the time the dispute was issued) which would mean EVG would receive $5m in the coming months. I really believed that would happen.
But unfortunately something doesn’t seem right yet again. It’s getting on for 7 weeks since the dispute was issued and still no updates. No mention in last week’s presentation but fair enough, why should shareholders be kept up to date with important issues. The placing last week seems to confirms EVG know that the $5m to be received once the Stalicla deal goes into phase 2 is not going to happen any time soon because why dilute the shares yet again if there is no need?
What is going on here? The Stalicla deal is supposed to be worth $163m plus royalties and yet after receiving only $500k there are disputes and continued delays to expected payments.
I’m starting to think this Stalicla deal is going to fall through and if it does what are EVG left with? I wish that Stalicla deal had never happened, it made a lot of us buy in believing there would be an income stream which would bankroll the company.
Can’t find fault with any of that LWHL. When I bought in on the Stalicla news in Nov 2022 I really thought this looked an amazing investment, one which I would double, treble or quadruple my money on. I should have known it was another AIM share that looked promising but would end up a disaster. I don’t think I’ve ever seen a golden AIM share that was successful. They all seem to be a way for those involved to make good salaries with no personal risk.
I think you hit the nail on the head with stating that SFX-01 is years off being commercialised whilst any company doing a deal with EVG for SFX-01 would take years doing trials on the drug. Evgen do not have the time or money for that.
Evgen were incorporated in 2014, what have they been doing for 10 years to have one drug and for it to still be so far away from being used in any way?
I’m fed up of how those running Evgen see shareholders as something they have trodden in. They lied about they couldn’t buy shares, they never told us why Juvenesense pulled the plug, they never explained why the $5.5m to be received by Stalicla in 2023 changed, they aren’t giving us any information about the Stalicla dispute. What a huge disappointment Evgen have been.
We have now passed six weeks since the dispute to Stalicla was issued and still no news on what is happening with the deal. There was no mention of it in this week’s presentation.
This week EVG issued a placing of shares, if I’ve read right they have issued a placing of shares that has diluted the shares by almost 50% which makes it far harder for shareholders to get their money back. Why would you issue a share placing diluting the shares if you are expecting $5.5m this year from Stalicla? It’s as if they know that money is not coming this year now.
This is becoming a mess IMO. Once a company starts shifting focus elsewhere from what their main operations it’s a sign that it’s game over.
It’s been a terribly disappointing last 12 months for EVG. No new deals signed whatsoever despite EVG trying hard to do so. Huw was out in California trying to network and EVG were present at events trying to drum up interest from other pharmas, but all to no avail.
Evgen lost the Juvenesense deal which was going to be a vital income stream. The $5.5m to be received by end of 2023 changed to expected up to $5.5m in 2024 but that is now looking less likely since Stalicla removed that this would go into phase 2 this year. Add to that the cash reserves have been falling from having decent funds in 2022 to running out this year. And now we have a share placing that many of us feared would happen.
What looked like an amazing investment opportunity now looks a sorry mess.
It’s still a hold for me. I feel you’ve got nothing to lose by holding this, the dividend will be 22p a share, the share price will drop by 20p after ex dividend date but no way is 470p a fair price, it’s worth far more than that.
I’ll be holding for the dividend and holding after the dividend. Still plenty more to come from Aviva IMO. We are finally seeing a price correction here.